高级检索+

利用ChIP-seq/双荧光素酶报告基因技术验证PPARγ2的靶向基因MYH7

Verification of the PPARγ2 Target Gene MYH7 by ChIP-seq Com-bined with Dual-luciferase Assay

  • 摘要: 为验证2型过氧化物酶体增殖激活受体γ(peroxisome proliferator-activated receptorγ2, PPARγ2)对编码β-肌球蛋白重链(β-myosin heavy chain,β-MHC)基因MYH7的靶向调控机制及其结合位点,本研究将pTT5空载体和pTT5-3flag-PPARγ2质粒分别转染小鼠心肌细胞(mouse cardiac myocytes, MCM),RT-qPCR和Western blot检测MYH7和PPARγ2的表达情况;利用染色质免疫共沉淀技术(chromatin immunoprecipita-tion, ChIP)特异性富集并纯化MCM中可与PPARγ2结合的DNA片段,通过高通量测序技术(high-throughput sequencing, HiSeq)检测和分析可直接与PPARγ2结合的基因。采用生物信息学软件预测PPARγ2结合于靶标基因MYH7的启动子区,并将预测到的转录因子结合位点和相应的突变位点分别插入pgl3-basic载体的萤火虫荧光素酶基因上游,构建野生型和突变型荧光素酶报告质粒,再分别与pcDNA3.1载体、pcDNA3.1-PPARγ2质粒和海肾荧光素酶基因载体pRL-TK共转染293T细胞,检测荧光素酶相对活性。实验结果表明:ChIP-seq初步验证了MYH7是PPARγ2直接调控的可能靶向基因;经基因测序验证MYH7野生型和突变型荧光素酶质粒(pgl3-basic-MYH7-WT、pgl3-basic-MYH7-mut)构建成功;双荧光素酶报告基因检测显示,与MYH7-WT+pcDNA3.1组的相对荧光素酶活(0.366±0.021)相比,MYH7-WT+pcDNA3.1-PPARγ2组的相对荧光素酶活性(2.477±0.212)增强,差异具有统计学意义(P<0.001);与MYH7-WT+pcDNA3.1-PPARγ2的相对荧光素酶活(2.477±0.212)相比,MYH7-mut+pcDNA3.1-PPARγ2组的相对荧光素酶活性(2.677±0.201)无明显变化(P>0.05)。本研究通过ChIP-seq/双荧光素酶报告基因技术初步验证PPARγ2能够直接结合MYH7的启动子区域并靶向正调控MYH7基因的表达。

     

    Abstract: To clarify the targeted regulation mechanism and binding sites of PPARγ2(peroxisome proliferator-activated receptor γ2) on the MYH7 gene encoding β-myosin heavy chain(β-MHC). In this study, the pTT5 basic vector and pTT5-3 flag-PPARγ2 plasmid were transfected into mouse cardiac myocytes(MCM), respectively, and the expression of MYH7 and PPARγ2 was detected by RT-qPCR and Western blot. Chromatin immunoprecipitation(ChIP) was used to specifically enrich and purify DNA fragments binding to PPARγ2 in the MCM, and high-throughput sequencing(HiSeq) was used to detect and analyze genes that can directly bind to PPARγ2. Relevant bioinformatics software was used to predict PPARγ2 binding to the promoter of the MYH7 gene, and inserted the predicted transcription factor binding site and corresponding mutation site into the upstream of the luciferase gene in the pgl3-basic vector, respectively. Wild and mutant types of dual-luciferase reporter plasmid were constructed. Meanwhile, they were co-transfected into 293 T cells with pcDNA3.1 vector, pcDNA3.1-PPARγ2 plasmid and renilla luciferase gene vector pRL-TK. Afterwards, the relative luciferase activity was detected. The results showed that ChIP-seq preliminarily verified that MYH7 was a possible target gene directly regulated by PPARγ2. The wild and mutant types of dual-luciferase reporter plasmids(pgl3-basic-MYH7-WT and pgl3-basic-MYH7-mut) were successfully built that identified by gene sequencing. Double fluorescence detection results showed that the relative luciferase activity of MYH7-WT+pcDNA3.1-PPARγ2(2.477±0.212) was higher than that of MYH7-WT+pcDNA3.1(0.366±0.021), and the difference was statistically significant(P<0.001). There was no difference in the relative luciferase activity between groups MYH7-WT+pcDNA3.1-PPARγ2(2.477±0.212)and MYH7-mut+pcDNA3.1-PPARγ2(2.677±0.201)(P>0.05). In this study, ChIP-seq and dual-luciferase assay technique preliminarily confirm that PPARγ2 can directly bind to the promoter region of MYH7 and have a regulatory positive effect on the MYH7 gene.

     

/

返回文章
返回